Skip to Content

American Century Mid Cap Value R AMVRX

Medalist Rating as of | See American Century Investment Hub
  • NAV / 1-Day Return 15.28  /  −0.84 %
  • Total Assets 8.5 Bil
  • Adj. Expense Ratio
    1.480%
  • Expense Ratio 1.480%
  • Distribution Fee Level High
  • Share Class Type Retirement, Medium
  • Category Mid-Cap Value
  • Investment Style Mid Value
  • Min. Initial Investment 2,500
  • Status Open
  • TTM Yield 1.20%
  • Turnover 64%

USD | NAV as of Apr 16, 2024 | 1-Day Return as of Apr 16, 2024, 10:11 PM GMT+0

Morningstar’s Analysis AMVRX

Will AMVRX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Sticking to its knitting.

Analyst Drew Carter

Drew Carter

Analyst

Summary

We have qualitatively reviewed American Century Mid Cap Value and reaffirmed its Process and People ratings. The team’s strong leader and process remain in place, and his team has been steady. One-year returns (through Sept. 30, 2023), while disappointing, have not been out of character, as growth gains left this defensive strategy out of favor. The following text is from Oct. 31, 2022.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings AMVRX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 21.4
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Zimmer Biomet Holdings Inc

3.06 273.9 Mil
Healthcare

Conagra Brands Inc

2.41 216.0 Mil
Consumer Defensive

Northern Trust Corp

2.17 194.0 Mil
Financial Services

Bank of New York Mellon Corp

2.13 190.4 Mil
Financial Services

Enterprise Products Partners LP

2.04 182.6 Mil
Energy

Kimberly-Clark Corp

2.00 178.8 Mil
Consumer Defensive

Henry Schein Inc

1.99 178.1 Mil
Healthcare

Quest Diagnostics Inc

1.98 176.9 Mil
Healthcare

Koninklijke Ahold Delhaize NV

1.87 167.4 Mil
Consumer Defensive

Allstate Corp

1.74 155.4 Mil
Financial Services